Enliven Therapeutics, Inc.

Direct answer

Enliven Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ELVN.

Enliven Therapeutics, Inc. is a biopharmaceutical enterprise, currently in the clinical development phase, dedicated to discovering and advancing small molecule therapeutic agents aimed at combating cancer. Its pipeline includes ELVN-001, a small molecule kinase inhibitor currently in a Phase 1 clinical trial for adult patients with chronic myeloid leukemia. Another key candidate, ELVN-002, also a small molecule...

Can you invest in Enliven Therapeutics, Inc.?

Yes. Enliven Therapeutics, Inc. trades publicly on NASDAQ as ELVN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Enliven Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.